큐리옥스바이오시스템즈
445680KOSDAQ49.5 / 100
Reference Date: 2026-10-23
Company InformationBased on 2025 Annual Report
Business Overview
Curiox Biosystems sells automated equipment and consumables for cell analysis processes, leveraging its decade-long developed Curiox C-FREE™ technology to automate preprocessing steps, significantly improving data accuracy and reproducibility. This technology, based on microfluidics and surface science, is used by pharmaceutical companies and research institutions in the US, Europe, and China. The company has subsidiaries in the US, China, and Singapore to expand its global market presence.
Number of Employees
22people
Average Salary
70.4M KRW
Score Calculation Basis
Detailed Financial Score
16.1x industry avg (risky)
Well below industry avg
Half of industry avg (excellent)
Avg ▼10.1% (2-year basis)
Avg ▼9.4% (2-year basis)
Avg ROE -30.1% (declining, 3yr)
Detailed News Sentiment
Detailed Momentum
52w lower range (23%)
1m +26.15% (strong rise)
Volume surge
Detailed Disclosure
- Neutral임원ㆍ주요주주특정증권등거래계획보고서2026-10-02
- Neutral[기재정정]사업보고서 (2025.12)2026-10-01
- Neutral[기재정정]사업보고서 (2024.12)2026-10-01
- Neutral[기재정정]사업보고서 (2023.12)2026-10-01
